P. V. Dam

发表

Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression

F. Bertucci, C. Colpaert, L. Dirix, 2019, Breast Cancer Research.

Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression

E. van Marck, S. Fox, A. Harris, 2003, British Journal of Cancer.

Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival.

F. Bertucci, W. Woodward, W. Symmans, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Alterations in the p53 pathway and prognosis in advanced ovarian cancer: a multi-factorial analysis of the EORTC Gynaecological Cancer group (study 55865).

P. V. van Diest, E. Berns, M. Vijver, 2006, European journal of cancer.

Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients.

P. V. van Dam, W. Tjalma, I. Vergote, 1998, Gynecologic oncology.

Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study

E. van Marck, P. V. van Dam, C. Colpaert, 2006, British Journal of Cancer.

The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients

E. van Marck, P. V. van Dam, I. Van der Auwera, 2009, British Journal of Cancer.

Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype

B. X. Trinh, E. van Marck, P. V. van Dam, 2008, British Journal of Cancer.

Intratumoral hypoxia resulting in the presence of a fibrotic focus is an independent predictor of early distant relapse in lymph node‐negative breast cancer patients

E. van Marck, J. Weyler, C. Colpaert, 2001, Histopathology.

Validation of a Tissue Microarray to Study Differential Protein Expression in Inflammatory and Non-Inflammatory Breast Cancer

S. Merajver, E. van Marck, A. Harris, 2004, Breast Cancer Research and Treatment.

Distinct molecular phenotype of inflammatory breast cancer compared to non-inflammatory breast cancer using Affymetrix-based genome-wide gene-expression analysis

E. van Marck, P. V. van Dam, G. G. Van den Eynden, 2007, British Journal of Cancer.

Prognostic value of bcl-2 expression in patients with operable carcinoma of the uterine cervix.

E. van Marck, J. Weyler, W. Tjalma, 1997, Journal of clinical pathology.

Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype

I. Van der Auwera, R. Limame, P. van Dam, 2010, British Journal of Cancer.

Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer

P. V. van Dam, R. Salgado, C. Colpaert, 2002, British Journal of Cancer.

Comparative analysis of the biochemical and immunohistochemical determination of hormone receptors in invasive breast carcinoma influence of the tumor-stroma ratio.

E. van Marck, J. Weyler, C. Colpaert, 2002, Pathology, research and practice.

Prognostic value of bcl-2 expression in invasive breast cancer.

E. van Marck, P. V. van Dam, J. Weyler, 1995, British Journal of Cancer.

Quantification and prognostic relevance of angiogenic parameters in invasive cervical cancer.

A. Van Daele, A. Van Daele, E. van Marck, 1998, British Journal of Cancer.

Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype

L. Dirix, Peter B. Vermeulen, I. Auwera, 2010, British Journal of Cancer.

Real-time RT–PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer

P. Dam, P. Vermeulen, L. Dirix, 2006, British Journal of Cancer.